They found that three features, which include granulocyte MAPKAPK2 signaling, stromal CD4+ memory T cell size, and the distance of fibroblast from the tumor border, were associated with clinical outcome and thereby provided a framework for analyzing complex imaging data to discover prognostic biomarkers. This evidence concerns the gene CD4 and neoplasm.